Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAP and LEAP-5Y follow-up in early Parkinson's disease
NL-OMON55477Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levodopa + carbidopa in Parkinson's disease (PD), sponsored by Amsterdam University Medical Center. Primary endpoints: Mean total UPDRS difference at 80 weeks, Diagnostic accuracy of neurological examination parameters and 1 more. Started Aug 2011; status: active, not recruiting.
02
Drugs
levodopa + carbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON55477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55477.